Vaxcyte to Present at the Jefferies Virtual Healthcare Conference
27 mai 2021 16h05 HE
|
Vaxcyte, Inc.
FOSTER CITY, Calif., May 27, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
Vaxcyte Reports First Quarter 2021 Financial Results and Provides Business Update
11 mai 2021 16h10 HE
|
Vaxcyte, Inc.
FOSTER CITY, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
Vaxcyte Announces Publication of Preclinical Data Supporting the Potential of VAX-24 for the Prevention of Invasive Pneumococcal Disease
10 mai 2021 08h30 HE
|
Vaxcyte, Inc.
FOSTER CITY, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
Vaxcyte to Present at BofA Securities 2021 Health Care Conference
06 mai 2021 16h05 HE
|
Vaxcyte, Inc.
FOSTER CITY, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
Vaxcyte to Present at 20th Annual Needham Virtual Healthcare Conference
05 avr. 2021 16h30 HE
|
Vaxcyte, Inc.
FOSTER CITY, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
Vaxcyte Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
29 mars 2021 16h10 HE
|
Vaxcyte, Inc.
FOSTER CITY, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
Vaxcyte to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021
22 mars 2021 16h05 HE
|
Vaxcyte, Inc.
FOSTER CITY, Calif., March 22, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines...
Vaxcyte Announces Publication of Preclinical Proof-of-Concept Data Supporting Potential of VAX-A1, a Novel Conjugate Vaccine Designed to Prevent Group A Strep Infections
06 janv. 2021 08h15 HE
|
Vaxcyte, Inc.
FOSTER CITY, Calif., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent...
Vaxcyte Promotes Andrew Guggenhime to President and Chief Financial Officer
22 déc. 2020 08h00 HE
|
Vaxcyte, Inc.
FOSTER CITY, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...
Vaxcyte to Present at Evercore ISI 3rd Annual HealthCONx Conference
24 nov. 2020 16h05 HE
|
Vaxcyte, Inc.
FOSTER CITY, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel...